These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 17681162

  • 1. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF, Jahnsen J, Moum BA, Vatn MH, IBSEN Group.
    Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
    [Abstract] [Full Text] [Related]

  • 2. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ.
    Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
    [Abstract] [Full Text] [Related]

  • 3. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T, Banai J, Lakatos L, Czegledi Z, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp M, Papp J, Lakatos PL.
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [Abstract] [Full Text] [Related]

  • 4. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 5. Mucosal healing: impact on the natural course or therapeutic strategies.
    Vatn MH.
    Dig Dis; 2009 Feb; 27(4):470-5. PubMed ID: 19897962
    [Abstract] [Full Text] [Related]

  • 6. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G, Belgian Inflammatory Bowel Disease Research Group, North-Holland Gut Club.
    Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
    Fratila OC, Craciun C.
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
    [Abstract] [Full Text] [Related]

  • 9. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrügger RW.
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [Abstract] [Full Text] [Related]

  • 10. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study).
    Henriksen M, Jahnsen J, Lygren I, Aadland E, Schulz T, Vatn MH, Moum B, Ibsen Study Group.
    Scand J Gastroenterol; 2007 May; 42(5):602-10. PubMed ID: 17454881
    [Abstract] [Full Text] [Related]

  • 11. Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.
    Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, Stockbrügger RW, European Collaborative Study Group On Inflammatory Bowel Disease.
    Scand J Gastroenterol Suppl; 2006 May; (243):46-54. PubMed ID: 16782622
    [Abstract] [Full Text] [Related]

  • 12. Mucosal healing as a treatment for IBD?
    Papi C, Aratari A.
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):457-9. PubMed ID: 24654957
    [Abstract] [Full Text] [Related]

  • 13. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
    Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Scand J Gastroenterol; 2009 Jul; 44(4):431-40. PubMed ID: 19101844
    [Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice.
    Tursi A, Elisei W, Brandimarte G, Giorgetti G, Penna A, Castrignano V.
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):47-55. PubMed ID: 20184089
    [Abstract] [Full Text] [Related]

  • 15. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 16. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality.
    Oriuchi T, Hiwatashi N, Kinouchi Y, Takahashi S, Takagi S, Negoro K, Shimosegawa T.
    J Gastroenterol; 2003 Nov; 38(10):942-53. PubMed ID: 14614601
    [Abstract] [Full Text] [Related]

  • 17. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ, International Organization for the Study of Inflammatory Bowel Diseases.
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [Abstract] [Full Text] [Related]

  • 18. Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.
    Pineton de Chambrun G, Blanc P, Peyrin-Biroulet L.
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):915-27. PubMed ID: 27043489
    [Abstract] [Full Text] [Related]

  • 19. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy.
    López-Palacios N, Mendoza JL, Taxonera C, Lana R, López-Jamar JM, Díaz-Rubio M.
    Eur J Intern Med; 2011 Dec; 22(6):621-5. PubMed ID: 22075292
    [Abstract] [Full Text] [Related]

  • 20. Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.
    Sung JJ, Kamm MA, Marteau P.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):183-93. PubMed ID: 19929931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.